Bio Green Med SolutionBGMS -0.53%47 Current Ratio is 7.06 as of Mar. 2026, which is 22% above its 10-year median of 5.78. GuruFocus rates BGMS with a GF Score™ of 47/100 and a GF Value™ of $2.56 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,413 Biotechnology companies, Bio Green Med Solution ranks better than 68.58% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Bio Green Med Solution's current ratio for the quarter that ended in Mar. 2026 was 7.06.
Bio Green Med Solution has a current ratio of 7.06. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Bio Green Med Solution's Current Ratio or its related term are showing as below:
BGMS'
s Current Ratio Range Over the Past 10 Years
Min: 0.58 Med: 5.78 Max: 18.47
Current: 7.06
During the past 13 years, Bio Green Med Solution's highest Current Ratio was 18.47. The lowest was 0.58. And the median was 5.78.
BGMS's Current Ratio is ranked better than 68.58% of 1413
companies
in the Biotechnology industry
Industry Median: 3.89
vs BGMS: 7.06
Bio Green Med Solution (NAS:BGMS) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Bio Green Med Solution Current Ratio Related Terms
Bio Green Med Solution Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Bio Green Med Solution's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Green Med Solution Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio Green Med Solution's Current Ratio distribution charts can be found below:
* The bar in red indicates where Bio Green Med Solution's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Green Med Solution (BGMS) has a Current Ratio of 7.06 as of Mar. 2026. This is 22% above median its historical median of 5.78. Over the past decade, Bio Green Med Solution's Current Ratio has ranged from 0.58 to 18.47. According to the industry distribution chart, Bio Green Med Solution ranks #444 out of 1413 companies in the Biotechnology industry, placing it in the top 31.4%.
Is Bio Green Med Solution's Current Ratio too high?
Bio Green Med Solution's current Current Ratio of 7.06 is 22% above median its 10-year median of 5.78. Over the past 10 years, this metric has ranged from a low of 0.58 to a high of 18.47. The Biotechnology industry median Current Ratio is 3.89. Bio Green Med Solution's value of 7.06 is 81.5% above this industry median. Based on the distribution chart, Bio Green Med Solution ranks #444 out of 1413 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bio Green Med Solution has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio Green Med Solution's Current Ratio compare to FBLG and AIM?
According to the Biotechnology industry distribution chart, Bio Green Med Solution ranks #444 out of 1413 companies for Current Ratio. This puts Bio Green Med Solution in the upper half of its industry. The industry median Current Ratio is 3.89. Bio Green Med Solution's value of 7.06 is 81.5% above this benchmark. Historically, Bio Green Med Solution's own Current Ratio has ranged from 0.58 to 18.47 over the past decade. While the company's 10-year median is 5.78 vs. the industry median of 3.89, Bio Green Med Solution has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,413 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Green Med Solution's current Current Ratio of 7.06 is 81.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Green Med Solution's current Current Ratio is 7.06, which is 22% above median its own 10-year median of 5.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Green Med Solution stock overvalued right now?
Based on GuruFocus' analysis, Bio Green Med Solution (BGMS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.56, compared to a current price of $0.60 — trading 76.5% below its estimated fair value. The current Current Ratio is 7.06, which is 22% above median its 10-year median of 5.78 and 81.5% above the Biotechnology industry median of 3.89. Bio Green Med Solution's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Bio Green Med Solution (BGMS), the current Current Ratio is 7.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio Green Med Solution (BGMS) Overvalued in 2026?
Based on GuruFocus' analysis, Bio Green Med Solution stock appears to be undervalued.
The current stock price of $0.60 is trading 76.5% below its estimated GF Value™ of $2.56.
GuruFocus considers Bio Green Med Solution to be Possible Value Trap.
Key valuation signals for BGMS:
Current Ratio: 7.06 (22% above median its 10-year median of 5.78)
GF Value™: $2.56 vs. price of $0.60 (76.5% below fair value)
Industry Position: 81.5% above the Biotechnology median (#444 of 1413)
No single metric tells the full story. See the BGMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel. It also provides fire safety systems, including sprinkler systems, fire alarm systems, valves, and CO2 systems. The company operates across commercial, industrial, healthcare, and residential sectors, with a focus on distribution and compliance with applicable safety standards.
47GF Score
Get the complete analysis for BGMS
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BGMS has been successfully added to your 
